Literature DB >> 7815490

Hepatitis B virus X protein interacts with a probable cellular DNA repair protein.

T H Lee1, S J Elledge, J S Butel.   

Abstract

The mechanism of action of hepatitis B virus (HBV) X protein in transcriptional transactivation and in tumorigenesis remains obscure. We have used the yeast two-hybrid system to identify a cellular protein that can interact with HBV X protein. This protein, designated X-associated protein 1 (XAP-1), is a human homolog of the UV-damaged DNA-binding protein (UV-DDB) recovered from a monkey cell cDNA library. UV-DDB is presumed to be involved in DNA repair. The interaction between X protein and XAP-1 protein was verified by immunoprecipitation of yeast cell lysates expressing both proteins and by in vitro mixing with X protein expressed as a glutathione S-transferase fusion protein and XAP-1 protein either in HeLa cell extracts or synthesized by in vitro translation. We speculate that the interaction of X protein with a DNA repair protein may recruit cellular proteins to repair the partially double-stranded HBV genome or may modify cellular transcription processes. An effect on the cellular DNA repair system may explain a cofactor role for HBV in liver cancer development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7815490      PMCID: PMC188683     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  HBx gene of hepatitis B virus induces liver cancer in transgenic mice.

Authors:  C M Kim; K Koike; I Saito; T Miyamura; G Jay
Journal:  Nature       Date:  1991-05-23       Impact factor: 49.962

Review 2.  Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator.

Authors:  M T Rossner
Journal:  J Med Virol       Date:  1992-02       Impact factor: 2.327

Review 3.  The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses.

Authors:  A J Levine
Journal:  Virology       Date:  1990-08       Impact factor: 3.616

4.  Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice.

Authors:  T H Lee; M J Finegold; R F Shen; J L DeMayo; S L Woo; J S Butel
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

5.  Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.

Authors:  K Yaginuma; Y Shirakata; M Kobayashi; K Koike
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

7.  Identification of three essential regions of hepatitis B virus X protein for trans-activation function.

Authors:  M Arii; S Takada; K Koike
Journal:  Oncogene       Date:  1992-03       Impact factor: 9.867

8.  Hepatitis B virus X protein is not central to the viral life cycle in vitro.

Authors:  H E Blum; Z S Zhang; E Galun; F von Weizsäcker; B Garner; T J Liang; J R Wands
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

9.  HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions.

Authors:  H F Maguire; J P Hoeffler; A Siddiqui
Journal:  Science       Date:  1991-05-10       Impact factor: 47.728

10.  X protein of hepatitis B virus resembles a serine protease inhibitor.

Authors:  S Takada; K Koike
Journal:  Jpn J Cancer Res       Date:  1990-12
View more
  84 in total

1.  Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions.

Authors:  C R Madden; M J Finegold; B L Slagle
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Microinjection technique used to study functional interaction between p53 and hepatitis B virus X gene in apoptosis.

Authors:  X W Wang
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

3.  The hepatitis B virus X gene induces p53-mediated programmed cell death.

Authors:  P Chirillo; S Pagano; G Natoli; P L Puri; V L Burgio; C Balsano; M Levrero
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

4.  Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants.

Authors:  D Sitterlin; T H Lee; S Prigent; P Tiollais; J S Butel; C Transy
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival.

Authors:  N Lale Satiroglu Tufan; Zhaorui Lian; Jie Liu; Jingbo Pan; Patrick Arbuthnot; Michael Kew; Marcy M Clayton; Minghua Zhu; Mark A Feitelson
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

6.  Basal transcriptional regulation of human damage-specific DNA-binding protein genes DDB1 and DDB2 by Sp1, E2F, N-myc and NF1 elements.

Authors:  Anne F Nichols; Toshiki Itoh; Francesca Zolezzi; Stephanie Hutsell; Stuart Linn
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

Review 7.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

8.  Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras.

Authors:  N P Klein; R J Schneider
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

9.  Enhanced Stabilization of MCL1 by the Human T-Cell Leukemia Virus Type 1 bZIP Factor Is Modulated by Blocking the Recruitment of Cullin 1 to the SCF Complex.

Authors:  Risa Mukai; Takayuki Ohshima
Journal:  Mol Cell Biol       Date:  2016-11-28       Impact factor: 4.272

10.  Functional complementation of xeroderma pigmentosum complementation group E by replication protein A in an in vitro system.

Authors:  A Kazantsev; D Mu; A F Nichols; X Zhao; S Linn; A Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.